Zolendronate associated inflammatory orbital disease.

Bisphosphonate infusions are associated with adverse events in approximately a third of patients. Ocular complications are rare and even more so, inflammatory orbital disease. Bisphosphonate-induced orbital inflammation is not a well recognised complication and there have been only a few published case reports of this. We present a case of orbital inflammatory disease associated with zolendronate infusion.